Author

Dirk van Asseldonk

A HIGHER RED BLOOD CELL METHOTREXATE POLYGLUTAMATE 3 CONCENTRATION IS ASSOCIATED WITH METHOTREXATE DRUG-SURVIVAL IN PATIENTS WITH CROHN’S DISEASE
A HIGHER RED BLOOD CELL METHOTREXATE POLYGLUTAMATE 3 CONCENTRATION IS ASSOCIATED WITH METHOTREXATE DRUG-SURVIVAL IN PATIENTS WITH CROHN’S DISEASE

Dirk van Asseldonk  et al.

METHOTREXATE POLYGLUTAMATE CONCENTRATIONS IN TARGET COLONIC MUCOSA, AND WHITE BLOOD CELLS COMPARED TO NON-TARGET RED BLOOD CELLS OF PATIENTS WITH CROHN’S DISEASE
METHOTREXATE POLYGLUTAMATE CONCENTRATIONS IN TARGET COLONIC MUCOSA, AND WHITE BLOOD CELLS COMPARED TO NON-TARGET RED BLOOD CELLS OF PATIENTS WITH CROHN’S DISEASE

Dirk van Asseldonk  et al.

MERCAPTOPURINE TREATMENT USING THERAPEUTIC DRUG MONITORING IS EFFECTIVE IN ULCERATIVE COLITIS: A PLACEBO-CONTROLLED RANDOMIZED TRIAL
MERCAPTOPURINE TREATMENT USING THERAPEUTIC DRUG MONITORING IS EFFECTIVE IN ULCERATIVE COLITIS: A PLACEBO-CONTROLLED RANDOMIZED TRIAL

Dirk van Asseldonk  et al.

Item 1 - 3 / 3
1